Cagrisema
Diabetes Mellitus, Type 2
Phase III
Recruiting
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Sep 08, 2026
―
Nnc0705-0002
Healthy Volunteers, Cardiometabolic Diseases
Phase I
Recruiting
A Study to See How Safe a New Medicine (NNC0705-0002) is in Healthy People
Aug 27, 2026
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Novo Nordisk (NVON) have in its pipeline
NVON is currently developing the following drugs: Cagrisema, Nnc0705-0002, Semaglutide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.